ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment

June 1, 2001

Help Wanted: Varmus Irked by Having to Fill Jobs With Salaries NCI Can’t Afford to Pay

July 6, 2012

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

In Brief: Laird Myers Heads AACE, George Hill President Elect; Cal Tech’s Hood Receives Bertner Award

March 1, 1985

Daily Aspirin May Reduce Risk By 20 Percent, Study Says

February 28, 2014

Roswell Park’s Future “Bright” As Center Snares Leading Scientists, Hohn Says.

January 18, 2002